China Antithrombin Market Research Report 2017

Publisher Name :
Date: 05-Dec-2017
No. of pages: 96
Inquire Before Buying

The global Antithrombin market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

China plays an important role in global market, with market size of xx million USD in 2016 and will be xx million USD in 2022, with a CAGR of xx%.

This report studies the Antithrombin development status and future trend in China, focuses on top players in China, also splits Antithrombin by type and by applications, to fully and deeply research and reveal the market general situation and future forecast.

The major players in China market include

- rEVO Biologics

- Grifols

- Shire

- CSL Limited

- Kedrion

- Lee Bisolutions

- Scripps Laboratories

- Octapharma

- Dem ilac

- Diapharma Group

Geographically, this report splits the China market into six regions,

- South China

- East China

- Southwest China

- Northeast China

- North China

- Central China

- Northwest China

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into

- Lyophilized

- Liquid

On the basis of the end users/application, this report covers

- Therapeutics

- Research

- Diagnostics

If you have any special requirements, please let us know and we will offer you the report as you want.

China Antithrombin Market Research Report 2017

Table of Contents
China Antithrombin Market Research Report 2017
1 Antithrombin Overview
1.1 Product Overview and Scope of Antithrombin
1.2 Classification of Antithrombin by Product Category
1.2.1 China Antithrombin Sales (K Units) Comparison by Type (2012-2022)
1.2.2 China Antithrombin Sales (K Units) Market Share by Type in 2016
1.2.3 Lyophilized
1.2.4 Liquid
1.3 China Antithrombin Market by Application/End Users
1.3.1 China Antithrombin Sales (K Units) and Market Share Comparison by Applications (2012-2022)
1.3.2 Therapeutics
1.3.3 Research
1.3.4 Diagnostics
1.4 China Antithrombin Market by Region
1.4.1 China Antithrombin Market Size (Million USD) Comparison by Region (2012-2022)
1.4.2 South China Antithrombin Status and Prospect (2012-2022)
1.4.3 East China Antithrombin Status and Prospect (2012-2022)
1.4.4 Southwest China Antithrombin Status and Prospect (2012-2022)
1.4.5 Northeast China Antithrombin Status and Prospect (2012-2022)
1.4.6 North China Antithrombin Status and Prospect (2012-2022)
1.4.7 Central China Antithrombin Status and Prospect (2012-2022)
1.5 China Market Size (Sales and Revenue) of Antithrombin (2012-2022)
1.5.1 China Antithrombin Sales (K Units) and Growth Rate (%)(2012-2022)
1.5.2 China Antithrombin Revenue (Million USD) and Growth Rate (%)(2012-2022)
2 China Antithrombin Market Competition by Players/Manufacturers
2.1 China Antithrombin Sales and Market Share of Key Players/Manufacturers (2012-2017)
2.2 China Antithrombin Revenue and Share by Players/Manufacturers (2012-2017)
2.3 China Antithrombin Average Price (USD/Unit) by Players/Manufacturers (2012-2017)
2.4 China Antithrombin Market Competitive Situation and Trends
2.4.1 China Antithrombin Market Concentration Rate
2.4.2 China Antithrombin Market Share of Top 3 and Top 5 Players/Manufacturers
2.4.3 Mergers & Acquisitions, Expansion in China Market
2.5 China Players/Manufacturers Antithrombin Manufacturing Base Distribution, Sales Area, Product Types
3 China Antithrombin Sales and Revenue by Region (2012-2017)
3.1 China Antithrombin Sales (K Units) and Market Share by Region (2012-2017)
3.2 China Antithrombin Revenue (Million USD) and Market Share by Region (2012-2017)
3.3 China Antithrombin Price (USD/Unit) by Regions (2012-2017)
4 China "&B1&" Sales and Revenue by Type/ Product Category (2012-2017)"
4.1 China Antithrombin Sales (K Units) and Market Share by Type/ Product Category (2012-2017)
4.2 China Antithrombin Revenue (Million USD) and Market Share by Type (2012-2017)
4.3 China Antithrombin Price (USD/Unit) by Type (2012-2017)
4.4 China Antithrombin Sales Growth Rate (%) by Type (2012-2017)
5 China "&B1&" Sales by Application (2012-2017)"
5.1 China Antithrombin Sales (K Units) and Market Share by Application (2012-2017)
5.2 China Antithrombin Sales Growth Rate (%) by Application (2012-2017)
5.3 Market Drivers and Opportunities
6 China Antithrombin Players/Suppliers Profiles and Sales Data
6.1 rEVO Biologics
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Antithrombin Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 rEVO Biologics Antithrombin Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
6.1.4 Main Business/Business Overview
6.2 Grifols
6.2.1 Company Basic Information, Manufacturing Base and Competitors
6.2.2 Antithrombin Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Grifols Antithrombin Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
6.2.4 Main Business/Business Overview
6.3 Shire
6.3.1 Company Basic Information, Manufacturing Base and Competitors
6.3.2 Antithrombin Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Shire Antithrombin Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
6.3.4 Main Business/Business Overview
6.4 CSL Limited
6.4.1 Company Basic Information, Manufacturing Base and Competitors
6.4.2 Antithrombin Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 CSL Limited Antithrombin Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
6.4.4 Main Business/Business Overview
6.5 Kedrion
6.5.1 Company Basic Information, Manufacturing Base and Competitors
6.5.2 Antithrombin Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Kedrion Antithrombin Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
6.5.4 Main Business/Business Overview
6.6 Lee Bisolutions
6.6.1 Company Basic Information, Manufacturing Base and Competitors
6.6.2 Antithrombin Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Lee Bisolutions Antithrombin Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
6.6.4 Main Business/Business Overview
6.7 Scripps Laboratories
6.7.1 Company Basic Information, Manufacturing Base and Competitors
6.7.2 Antithrombin Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Scripps Laboratories Antithrombin Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
6.7.4 Main Business/Business Overview
6.8 Octapharma
6.8.1 Company Basic Information, Manufacturing Base and Competitors
6.8.2 Antithrombin Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Octapharma Antithrombin Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
6.8.4 Main Business/Business Overview
6.9 Dem ilac
6.9.1 Company Basic Information, Manufacturing Base and Competitors
6.9.2 Antithrombin Product Category, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Dem ilac Antithrombin Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
6.9.4 Main Business/Business Overview
6.10 Diapharma Group
6.10.1 Company Basic Information, Manufacturing Base and Competitors
6.10.2 Antithrombin Product Category, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Diapharma Group Antithrombin Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
6.10.4 Main Business/Business Overview
7 Antithrombin Manufacturing Cost Analysis
7.1 Antithrombin Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Antithrombin
8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Antithrombin Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Antithrombin Major Manufacturers in 2016
8.4 Downstream Buyers
9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
11 China Antithrombin Market Size (Sales and Revenue) Forecast (2017-2022)
11.1 China Antithrombin Sales (K Units), Revenue (Million USD) Forecast (2017-2022)
11.2 China Antithrombin Sales (K Units) Forecast by Type (2017-2022)
11.3 China Antithrombin Sales (K Units) Forecast by Application (2017-2022)
11.4 China Antithrombin Sales (K Units) Forecast by Region (2017-2022)
12 Research Findings and Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
List of Tables and Figures
Figure Global and China Market Size (Million USD) Comparison (2012-2022)
Table Antithrombin Sales (K Units) and Revenue (Million USD) Market Split by Product Type
Table Antithrombin Sales (K Units) by Application (2016-2022)
Figure Product Picture of Antithrombin
Table China Antithrombin Sales (K Units) and Growth Rate (%) Comparison by Types (Product Category) (2012-2022)
Figure China Antithrombin Sales Volume Market Share by Types in 2016
Figure Lyophilized Product Picture
Figure Liquid Product Picture
Figure China Antithrombin Sales (K Units) Comparison by Application (2012-2022)
Figure China Sales Market Share (%) of Antithrombin by Application in 2016
Figure Therapeutics Examples
Table Key Downstream Customer in Therapeutics
Figure Research Examples
Table Key Downstream Customer in Research
Figure Diagnostics Examples
Table Key Downstream Customer in Diagnostics
Figure South China Antithrombin Revenue (Million USD) and Growth Rate (2012-2022)
Figure East China Antithrombin Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest China Antithrombin Revenue (Million USD) and Growth Rate (2012-2022)
Figure Northeast China Antithrombin Revenue (Million USD) and Growth Rate (2012-2022)
Figure North China Antithrombin Revenue (Million USD) and Growth Rate (2012-2022)
Figure Central China Antithrombin Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Antithrombin Sales (K Units) and Growth Rate (%)(2012-2022)
Figure China Antithrombin Revenue (Million USD) and Growth Rate (%)(2012-2022)
Table China Antithrombin Sales of Key Players/Manufacturers (2012-2017)
Table China Antithrombin Sales Share (%) by Players/Manufacturers (2012-2017)
Figure 2016 China Antithrombin Sales Share (%) by Players/Manufacturers
Figure 2017 China Antithrombin Sales Share (%) by Players/Manufacturers
Table China Antithrombin Revenue by Players/Manufacturers (2012-2017)
Table China Antithrombin Revenue Market Share (%) by Players/Manufacturers (2012-2017)
Figure 2016 China Antithrombin Revenue Market Share (%) by Players/Manufacturers
Figure 2017 China Antithrombin Revenue Market Share (%) by Players/Manufacturers
Table China Market Antithrombin Average Price of Key Players/Manufacturers (2012-2017)
Figure China Market Antithrombin Average Price of Key Players/Manufacturers in 2016
Figure China Antithrombin Market Share of Top 3 Players/Manufacturers
Figure China Antithrombin Market Share of Top 5 Players/Manufacturers
Table China Players/Manufacturers Antithrombin Manufacturing Base Distribution and Sales Area
Table China Players/Manufacturers Antithrombin Product Category
Table China Antithrombin Sales (K Units) by Regions (2012-2017)
Table China Antithrombin Sales Share (%) by Regions (2012-2017)
Figure China Antithrombin Sales Share (%) by Regions (2012-2017)
Figure China Antithrombin Sales Market Share (%) by Regions in 2016
Table China Antithrombin Revenue (Million USD) and Market Share by Regions (2012-2017)
Table China Antithrombin Revenue Market Share (%) by Regions (2012-2017)
Figure China Antithrombin Revenue Market Share (%) by Regions (2012-2017)
Figure China Antithrombin Revenue Market Share (%) by Regions in 2016
Table China Antithrombin Price (USD/Unit) by Regions (2012-2017)
Table China Antithrombin Sales (K Units) by Type (2012-2017)
Table China Antithrombin Sales Share (%) by Type (2012-2017)
Figure China Antithrombin Sales Share (%) by Type (2012-2017)
Figure China Antithrombin Sales Market Share (%) by Type in 2016
Table China Antithrombin Revenue (Million USD) and Market Share by Type (2012-2017)
Table China Antithrombin Revenue Market Share (%) by Type (2012-2017)
Figure Revenue Market Share of Antithrombin by Type (2012-2017)
Figure Revenue Market Share of Antithrombin by Type in 2016
Table China Antithrombin Price (USD/Unit) by Types (2012-2017)
Figure China Antithrombin Sales Growth Rate (%) by Type (2012-2017)
Table China Antithrombin Sales (K Units) by Applications (2012-2017)
Table China Antithrombin Sales Market Share (%) by Applications (2012-2017)
Figure China Antithrombin Sales Market Share (%) by Application (2012-2017)
Figure China Antithrombin Sales Market Share (%) by Application in 2016
Table China Antithrombin Sales Growth Rate (%) by Application (2012-2017)
Figure China Antithrombin Sales Growth Rate (%) by Application (2012-2017)
Table rEVO Biologics Antithrombin Basic Information List
Table rEVO Biologics Antithrombin Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Figure rEVO Biologics Antithrombin Sales (K Units) and Growth Rate (%)(2012-2017)
Figure rEVO Biologics Antithrombin Sales Market Share (%) in China (2012-2017)
Figure rEVO Biologics Antithrombin Revenue Market Share (%) in China (2012-2017)
Table Grifols Antithrombin Basic Information List
Table Grifols Antithrombin Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Figure Grifols Antithrombin Sales (K Units) and Growth Rate (%)(2012-2017)
Figure Grifols Antithrombin Sales Market Share (%) in China (2012-2017)
Figure Grifols Antithrombin Revenue Market Share (%) in China (2012-2017)
Table Shire Antithrombin Basic Information List
Table Shire Antithrombin Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Figure Shire Antithrombin Sales (K Units) and Growth Rate (%)(2012-2017)
Figure Shire Antithrombin Sales Market Share (%) in China (2012-2017)
Figure Shire Antithrombin Revenue Market Share (%) in China (2012-2017)
Table CSL Limited Antithrombin Basic Information List
Table CSL Limited Antithrombin Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Figure CSL Limited Antithrombin Sales (K Units) and Growth Rate (%)(2012-2017)
Figure CSL Limited Antithrombin Sales Market Share (%) in China (2012-2017)
Figure CSL Limited Antithrombin Revenue Market Share (%) in China (2012-2017)
Table Kedrion Antithrombin Basic Information List
Table Kedrion Antithrombin Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Figure Kedrion Antithrombin Sales (K Units) and Growth Rate (%)(2012-2017)
Figure Kedrion Antithrombin Sales Market Share (%) in China (2012-2017)
Figure Kedrion Antithrombin Revenue Market Share (%) in China (2012-2017)
Table Lee Bisolutions Antithrombin Basic Information List
Table Lee Bisolutions Antithrombin Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Figure Lee Bisolutions Antithrombin Sales (K Units) and Growth Rate (%)(2012-2017)
Figure Lee Bisolutions Antithrombin Sales Market Share (%) in China (2012-2017)
Figure Lee Bisolutions Antithrombin Revenue Market Share (%) in China (2012-2017)
Table Scripps Laboratories Antithrombin Basic Information List
Table Scripps Laboratories Antithrombin Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Figure Scripps Laboratories Antithrombin Sales (K Units) and Growth Rate (%)(2012-2017)
Figure Scripps Laboratories Antithrombin Sales Market Share (%) in China (2012-2017)
Figure Scripps Laboratories Antithrombin Revenue Market Share (%) in China (2012-2017)
Table Octapharma Antithrombin Basic Information List
Table Octapharma Antithrombin Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Figure Octapharma Antithrombin Sales (K Units) and Growth Rate (%)(2012-2017)
Figure Octapharma Antithrombin Sales Market Share (%) in China (2012-2017)
Figure Octapharma Antithrombin Revenue Market Share (%) in China (2012-2017)
Table Dem ilac Antithrombin Basic Information List
Table Dem ilac Antithrombin Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Figure Dem ilac Antithrombin Sales (K Units) and Growth Rate (%)(2012-2017)
Figure Dem ilac Antithrombin Sales Market Share (%) in China (2012-2017)
Figure Dem ilac Antithrombin Revenue Market Share (%) in China (2012-2017)
Table Diapharma Group Antithrombin Basic Information List
Table Diapharma Group Antithrombin Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Figure Diapharma Group Antithrombin Sales (K Units) and Growth Rate (%)(2012-2017)
Figure Diapharma Group Antithrombin Sales Market Share (%) in China (2012-2017)
Figure Diapharma Group Antithrombin Revenue Market Share (%) in China (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Antithrombin
Figure Manufacturing Process Analysis of Antithrombin
Figure Antithrombin Industrial Chain Analysis
Table Raw Materials Sources of Antithrombin Major Players/Manufacturers in 2016
Table Major Buyers of Antithrombin
Table Distributors/Traders List
Figure China Antithrombin Sales (K Units) and Growth Rate (%) Forecast (2017-2022)
Figure China Antithrombin Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure China Antithrombin Price (USD/Unit) Trend Forecast (2017-2022)
Table China Antithrombin Sales (K Units) Forecast by Type (2017-2022)
Figure China Antithrombin Sales (K Units) Forecast by Type (2017-2022)
Figure China Antithrombin Sales Volume Market Share Forecast by Type in 2022
Table China Antithrombin Sales (K Units) Forecast by Application (2017-2022)
Figure China Antithrombin Sales Volume Market Share Forecast by Application (2017-2022)
Figure China Antithrombin Sales Volume Market Share Forecast by Application in 2022
Table China Antithrombin Sales (K Units) Forecast by Regions (2017-2022)
Table China Antithrombin Sales Volume Share Forecast by Regions (2017-2022)
Figure China Antithrombin Sales Volume Share Forecast by Regions (2017-2022)
Figure China Antithrombin Sales Volume Share Forecast by Regions in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Global and United States Saffron Extract Market Research by Company, Type & Application 2013-2025
    Published: 15-Jul-2018        Price: US 2000 Onwards        Pages: 123
    Summary Market Segment as follows: By Type - Thread - Powder - Liquid By Application - Food - Medical & Pharmaceuticals - Cosmetics - Others By Company - Safrante Global Company S.L.U. - Evolva - Rowhani Saffron Co - Sara Nuts - Tarvand Saffron Co - Hijos de Eustaquio Abad & Co. S.L. - USMS Saffron Co.Inc - Royal Saffron Company - Saharkhiz International Gro......
  • Global and United States Propolis Market Research by Company, Type & Application 2013-2025
    Published: 15-Jul-2018        Price: US 2000 Onwards        Pages: 152
    Summary Market Segment as follows: By Type - Supercritical Extraction CO2 (SFE) - Ethanol Extracted Propolis (EEP) - Glycol Extracted Propolis (GEP) - Others By Application - Food Industry - Cosmetic Industry - Pharmaceutical Industry - Others By Company - Apis Flora - Wax Green - Comvita - Polenectar - King's Gel - MN Propolis - Evergreen - Ponlee - ......
  • Global and United States Recombinant Protein Drugs Market Research by Company, Type & Application 2013-2025
    Published: 14-Jul-2018        Price: US 2000 Onwards        Pages: 130
    Summary Market Segment as follows: By Type - Recombinant DNA - Recombinant RNA By Application - Pharmaceutical Industry - Others By Company - Novo Nordisk - Amgen - Sanofi - Eli Lilly - Merck Serono - Ortho Biotech - Roche - Kyowa Hakko Kirin - Pharmingen - Abcam - GenSci - SL PHARM - Dongbao Pharm - Ankebio - NCPC - Heng Rui......
  • Global Streptokinase Market Research Report 2018
    Published: 13-Jul-2018        Price: US 2900 Onwards        Pages: 96
    This report studies the global Streptokinase market status and forecast, categorizes the global Streptokinase market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa. The global Streptokinase market is valued at million US$ in 2017 and will reach million US$ by the end of 2025, growing at a CAGR of during 2018-2025. The major ......
  • Global and United States P2X Purinoceptor 3 Market Research by Company, Type & Application 2013-2025
    Published: 13-Jul-2018        Price: US 2000 Onwards        Pages: 121
    Summary Market Segment as follows: By Type - OSX-300 - ASN-009 - BLU-5937 - Others By Application - Abdominal Pain - Endometriosis - Idiopathic Pulmonary Fibrosis - Insomnia - Interstitial - Others By Company - Asana BioSciences LLC - Bayer AG - BELLUS Health Inc - Integral Molecular Inc - Merck & Co Inc - Neurim Pharmaceuticals Ltd - Pfizer Inc......
  • Global and United States Nano Pharmaceutical Market Research by Company, Type & Application 2013-2025
    Published: 13-Jul-2018        Price: US 2000 Onwards        Pages: 131
    Summary Market Segment as follows: By Type - Natural Material Carrier - High Polymer Material Carrier By Application - Medical - Scientific Research - Others By Company - Sanofi - Merck - Pfizer - Cerulean Pharma - Selecta Biosciences - Nanobiotix - Magforce - Celgene - Celsion Corporation - Novsrtisnamiyaow - GSK - Eli Lilly - Astrazeneca......
  • Investigation Report on Chinese Pregabalin Market, 2018-2022
    Published: 13-Jul-2018        Price: US 2200 Onwards        Pages: 30
    Description Pregabalin is a new-generation drug for neuralgia treatment. In Jul. 2004, it was approved by the European Union to treat some epileptic seizures in adults. In Dec. 2004, it was approved by the U.S. Food and Drug Administration (FDA) to treat diabetic peripheral neuralgia and postherpetic neuralgia. In 2006, generalized anxiety disorder and social anxiety disorder became new indications of Pregabalin. In 2007, Pregabalin was approved by the FDA as the first drug to tre......
  • Investigation Report on Chinese Epoetin Alfa Market, 2018-2022
    Published: 13-Jul-2018        Price: US 2200 Onwards        Pages: 30
    Description Epoetin Alfa refers to erythropoietin (EPO). EPO in the human body is a hormone-like substance secreted by the kidneys and liver to promote erythropoiesis. The indications for EPO approved in China are renal anemia, chemotherapy-induced anemia, and perioperative erythrocyte mobilization. In Jun. 1989, FDA-approved Epoetin Alfa was launched in the U.S. in the trade name of "Epogen". It is sold in over 40 countries nowadays. The report in ......
  • Global and United States Recombinant Peptides Market Research by Company, Type & Application 2013-2025
    Published: 12-Jul-2018        Price: US 2000 Onwards        Pages: 117
    Summary Market Segment as follows: By Type Glucagon Calcitonin Others By Application Oncology Blood Disorders Infectious Diseases Autoimmune Diseases Others By Company Sandoz Pharma Stada Arzneimittel Amgen Hospira Actavis Cipla Ltd. Wockhardt Ltd. Biocon Ltd. The main contents of the report including: ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs